Hummingbird is harnessing the predictive power of blood-borne miRNAs to provide insights into human health and disease. Analysis of miRNAs with Hummingbird’s platform holds the potential for early disease detection, disease-specific prognostics, treatment response prediction, and the development of patient-centric therapies.
The privately held company is based in Heidelberg, Germany.
We are Hummingbird Diagnostics
Hummingbird’s dedicated and experienced team is committed to delivering results for patients.
We have developed best-in-class expertise in processing and analyzing blood-borne miRNAs, evaluating the immune system‘s response to disease with a proven track record in molecular diagnostics, clinical laboratory sciences, computational biology as well as in statistical machine learning and artificial intelligence.
Our success rests upon a strong team!
Currently, there are no positions available.
